Diphenhydramine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Diphenhydramine Market is segmented by Dosage Forms (Tablets, Injection, Powder, and Syrups), Application, and Geography.

Market Snapshot

Diphenhydramine Market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The diphenhydramine market is expected to register a CAGR of 2% during the forecast period. This is attributing to an increasing number of allergies worldwide.

  • Diphenhydramine is used for the treatment of allergies, and it is first line of therapy for the same. Increasing levels of indoor and outdoor pollution, changing lifestyle, poor dietary habits, and rapid urbanization across the world are few of the factors due to which patients suffering from allergies are rapidly increasing. As per the International Study of Asthma and Allergies in Childhood (ISAAC), 22.1% of children of age 13- and 14-years experienced hay fever. This high incidence of the targeted patient pool result in propelling the market to a certain extent. However, few side effects associated with consuming diphenhydramine hinder the market.

Scope of the Report

Diphenhydramine is an antihistamine used to treat allergy, hay fever, and cold. It reduces the effect of the natural chemical histamine in the body. It is also used to prevent nausea, vomiting, and motion sickness.

By Dosage Forms
Tablets
Injection
Powder
Syrups
By Application
Allergies
Insomnia
Cold
Nausea
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Tablets Form is Estimated to Witness a Healthy Growth in the Future

The tablets form segment is estimated to witness healthy growth in the future, owing to the wide availability of drugs, low cost of manufacturing, ease of administration, and convenience in storage. Several advantages of tablets, along with an increasing number of allergic populations worldwide, are the key drivers contributing to the growth of the diphenhydramine market.

img

North America is Expected to Hold a Significant Share in the Market and is Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global diphenhydramine market, due to the increasing number of allergic populations. As per the data published by the American College of Allergy, Asthma, & Immunology, allergies are the 6th leading cause of chronic illness in the United States, and every year, more than 50 million Americans suffer from allergies. Thus, the increasing burden of allergic diseases is expected to aid the demand for diphenhydramine drugs and further propel the growth of the market in this region. Moreover, the increasing healthcare expenditure and the presence of well-established healthcare infrastructure are also fueling the growth of the overall regional market to a large extent.

geography diohenhydramine.png

Competitive Landscape

The diphenhydramine market is moderately competitive and consists of several major players. Some of the companies, which are currently dominating the market, are Cardinal Health, Pharmaceutical Associated, Bayer AG, Pfizer Inc., Johnson & Johnson, Cigna, RemedyLabs, and Fresenius Kabi.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Number of Allergic Population

      2. 4.2.2 Increasing R&D Expenditure

    3. 4.3 Market Restraints

      1. 4.3.1 Side Effects

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Dosage Forms

      1. 5.1.1 Tablets

      2. 5.1.2 Injection

      3. 5.1.3 Powder

      4. 5.1.4 Syrups

    2. 5.2 By Application

      1. 5.2.1 Allergies

      2. 5.2.2 Insomnia

      3. 5.2.3 Cold

      4. 5.2.4 Nausea

      5. 5.2.5 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Cardinal Health

      2. 6.1.2 Pharmaceutical Assocaites

      3. 6.1.3 Bayer Healthcare

      4. 6.1.4 Pfizer Inc.

      5. 6.1.5 Johnson and Johnson

      6. 6.1.6 Cigna

      7. 6.1.7 Remedy Labs

      8. 6.1.8 Wan Bury

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Diphenhydramine Market market is studied from 2018 - 2026.

The Diphenhydramine Market is growing at a CAGR of 2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

PHARMACEUTICAL ASSOCIATES, PFIZER, Johnson & Johnson, CIGNA, Fresenius Kabi are the major companies operating in Diphenhydramine Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!